PMID: 9178844May 9, 1997Paper

Local treatment with the N-methyl-D-aspartate receptor antagonist ketamine, inhibit development of secondary hyperalgesia in man by a peripheral action

Neuroscience Letters
T WarnckeA Stubhaug

Abstract

Due to the recent discovery of peripheral N-methyl-D-aspartate (NMDA) (and other glutamate) receptors in animal studies, the NMDA receptor antagonist, ketamine (0.83 mg/ml, 6 ml) or saline was injected s.c. preinjury in 10 healthy volunteers, to study the effect on burn-induced primary and secondary hyperalgesia. On the saline treated leg, all subjects developed primary hyperalgesia and secondary hyperalgesia. On the contralateral leg treated with ketamine, there was a significant reduction of primary hyperalgesia and an inhibition of development of secondary hyperalgesia. In an experimental day 2, lidocaine temporarily blocked the development of primary and secondary hyperalgesia. When saline was injected in the contralateral leg treated with ketamine 1 week previously (n = 6), no zone of secondary hyperalgesia was developed. In contrast, subjects (n = 3) treated with ketamine 2 weeks before, reported development of secondary hyperalgesia following saline, a preliminary indication of a long-lasting peripheral action of ketamine.

References

Apr 1, 1977·The Journal of Pharmacology and Experimental Therapeutics·B B Shrivastav
Sep 1, 1992·British Journal of Anaesthesia·C Frenkel, B W Urban
Feb 1, 1986·British Journal of Pharmacology·E BenoitD Mitolo-Chieppa
Jul 31, 1986·European Journal of Pharmacology·P Arhem, B Rydqvist
Mar 1, 1989·Anesthesia and Analgesia·Z DurraniM L Burnett
Jan 1, 1950·The Journal of Clinical Investigation·J D HARDYH GOODELL

❮ Previous
Next ❯

Citations

Mar 10, 2004·Arthroscopy : the Journal of Arthroscopic & Related Surgery : Official Publication of the Arthroscopy Association of North America and the International Arthroscopy Association·Didem DalMahmut Nedim Doral
Nov 8, 2001·European Journal of Pharmacology·C G Parsons
Feb 13, 1999·Progress in Neurobiology·M J Millan
Mar 31, 2000·Neuroscience Letters·I KinkelinS M Carlton
Nov 20, 2001·Current Opinion in Pharmacology·S M Carlton
Sep 23, 2010·Journal of Endourology·Reza Shariat MoharariMohammad Reza Nikoobakht
Oct 10, 2002·Regional Anesthesia and Pain Medicine·Takahiro UshidaHiroshi Yamamoto
Dec 13, 2005·The Clinical Journal of Pain·Reino Pöyhiä, Anneli Vainio
Sep 17, 2003·Pain Medicine : the Official Journal of the American Academy of Pain Medicine·Neal E Slatkin, Michelle Rhiner
Feb 14, 2007·International Journal of Pediatric Otorhinolaryngology·Omer Lütfi ErhanAzize Beştaş
Apr 2, 2004·Clinical Physiology and Functional Imaging·Hanne GottrupTroels Staehelin Jensen
Mar 5, 2015·Acta Anaesthesiologica Scandinavica·V M RasmussenM U Werner
Aug 22, 2014·Lancet Neurology·Troels S Jensen, Nanna B Finnerup
Jul 23, 2013·Journal of the American Academy of Dermatology·Timothy J PoteruchaMark D P Davis
Sep 22, 2009·Pain·Susan M Carlton
Dec 7, 2007·Anesthesiology Clinics·Gary McCleane
Jun 1, 2000·Annals of Emergency Medicine·J Ducharme
Nov 7, 2000·British Journal of Anaesthesia·H GottrupT S Jensen
Jul 17, 1998·Anesthesiology·J L PedersenH Kehlet
Sep 23, 2003·Anesthesia and Analgesia·Andrei B PetrenkoKoki Shimoji

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.